The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

Actions
  • Price (GBX)927.00
  • Today's Change-21.00 / -2.22%
  • Shares traded32.72k
  • 1 Year change+23.11%
  • Beta0.5940
Data delayed at least 20 minutes, as of Nov 26 2024 12:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments2.132.770
Total Receivables, Net------
Total Inventory------
Prepaid expenses0.030.020.05
Other current assets, total150.490
Total current assets173.280.05
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments395357427
Note receivable - long term------
Other long term assets0.04----
Total assets411361427
LIABILITIES
Accounts payable------
Accrued expenses----0
Notes payable/short-term debt472032
Current portion long-term debt/capital leases------
Other current liabilities, total2.019.100.45
Total current liabilities503033
Total long term debt000
Total debt472032
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities503033
SHAREHOLDERS EQUITY
Common stock8.379.6810
Additional paid-in capital808080
Retained earnings (accumulated deficit)273241304
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity361330394
Total liabilities & shareholders' equity411361427
Total common shares outstanding333941
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.